These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12234781)

  • 1. Antiadrenergic effects of adenosine A(1) receptor-mediated protein phosphatase 2a activation in the heart.
    Liu Q; Hofmann PA
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1314-21. PubMed ID: 12234781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPK.
    Liu Q; Hofmann PA
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H97-103. PubMed ID: 12649078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitor.
    Deshmukh PA; Blunt BC; Hofmann PA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H792-9. PubMed ID: 17012362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia.
    Marshall M; Anilkumar N; Layland J; Walker SJ; Kentish JC; Shah AM; Cave AC
    Cardiovasc Res; 2009 Apr; 82(1):67-76. PubMed ID: 19201758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase inhibitor cantharidin blocks adenosine A(1) receptor anti-adrenergic effect in rat cardiac myocytes.
    Narayan P; Mentzer RM; Lasley RD
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H1-7. PubMed ID: 10644577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1.
    Snabaitis AK; D'Mello R; Dashnyam S; Avkiran M
    J Biol Chem; 2006 Jul; 281(29):20252-62. PubMed ID: 16707501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.
    Kirchhefer U; Brekle C; Eskandar J; Isensee G; Kučerová D; Müller FU; Pinet F; Schulte JS; Seidl MD; Boknik P
    J Biol Chem; 2014 Dec; 289(49):33862-73. PubMed ID: 25320082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation.
    Dobson JG; Shea LG; Fenton RA
    Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1471-8. PubMed ID: 12805016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation.
    Bokník P; Fockenbrock M; Herzig S; Knapp J; Linck B; Lüss H; Müller FU; Müller T; Schmitz W; Schröder F; Neumann J
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):222-31. PubMed ID: 10997724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium.
    Gupta RC; Neumann J; Watanabe AM; Sabbah HN
    Biochem Pharmacol; 2002 Mar; 63(6):1069-76. PubMed ID: 11931839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiadrenergic effects of adenosine in pressure overload hypertrophy.
    Meyer TE; Chung ES; Perlini S; Norton GR; Woodiwiss AJ; Lorbar M; Fenton RA; Dobson JG
    Hypertension; 2001 Mar; 37(3):862-8. PubMed ID: 11244009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.
    Sulakhe PV; Vo XT
    Mol Cell Biochem; 1995; 149-150():103-26. PubMed ID: 8569720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
    Ranieri A; Kemp E; Burgoyne JR; Avkiran M
    J Mol Cell Cardiol; 2018 Feb; 115():20-31. PubMed ID: 29294329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of protein phosphatases in hypoxic preconditioning.
    Ladilov Y; Maxeiner H; Wolf C; Schäfer C; Meuter K; Piper HM
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1092-8. PubMed ID: 12181139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin I phosphorylation in spontaneously hypertensive rat heart: effect of beta-adrenergic stimulation.
    McConnell BK; Moravec CS; Morano I; Bond M
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1440-51. PubMed ID: 9321836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclopentyladenosine on isoproterenol response in adult and senescent cardiac tissue from Fischer 344 rats.
    Kapicka CL; Montamat SC; Mudumbi RV; Jacks SM; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 2000 May; 293(2):599-606. PubMed ID: 10773034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
    Chern Y; Chiou JY; Lai HL; Tsai MH
    Mol Pharmacol; 1995 Jul; 48(1):1-8. PubMed ID: 7623763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of beta-adrenoceptor and adenosine receptor agonists on phosphorylation. Identification of target proteins in mammalian ventricles.
    Neumann J; Gupta RC; Jones LR; Bodor GS; Bartel S; Krause EG; Pask HT; Schmitz W; Scholz H; Watanabe AM
    J Mol Cell Cardiol; 1995 Aug; 27(8):1655-67. PubMed ID: 8523428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart.
    Norton GR; Woodiwiss AJ; McGinn RJ; Lorbar M; Chung ES; Honeyman TW; Fenton RA; Dobson JG; Meyer TE
    Am J Physiol; 1999 Feb; 276(2):H341-9. PubMed ID: 9950832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts.
    Neumann J; Maas R; Bokník P; Jones LR; Zimmermann N; Scholz H
    J Pharmacol Exp Ther; 1999 Apr; 289(1):188-93. PubMed ID: 10087003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.